Literature DB >> 8944861

Cost effectiveness of personal health education in primary care for people with angina in the greater Belfast area of Northern Ireland.

C O'Neill1, C Normand, M Cupples, A McKnight.   

Abstract

STUDY
OBJECTIVE: To investigate the cost effectiveness of personal health education for angina patients being treated in general practice.
DESIGN: A randomised controlled trial in which people were randomised to intervention and control groups. All were assessed at the start and end of the study, with details recorded of disease status, coronary heart disease risk factors, and self assessed quality of life. A note was taken of their current use of drugs and over the course of the study their use of all health services. Those in the intervention group had three visits per year from a health visitor, whose brief was discuss ways of living more easily with their disease and in which risks of further events might be reduced. PATIENTS: Altogether 688 patents in the Greater Belfast area aged less than 75 years and known to have angina for at least six months. MAIN
RESULTS: Significant improvements in survival and self assessed quality of life were found between the study and control groups. The intervention was associated with a reduction in drug usage and there was no significant difference between the intervention and control groups in terms of their use of other health services.
CONCLUSION: Given the improvement in survival and self assessed quality of life and no significant differences in costs to the health service between the two groups, the intervention was deemed to be cost effective.

Entities:  

Mesh:

Year:  1996        PMID: 8944861      PMCID: PMC1060346          DOI: 10.1136/jech.50.5.538

Source DB:  PubMed          Journal:  J Epidemiol Community Health        ISSN: 0143-005X            Impact factor:   3.710


  4 in total

1.  Counselling patients to make lifestyle changes: the role of physician self-efficacy, training and beliefs about causes.

Authors:  S C Thompson; L Schwankovsky; J Pitts
Journal:  Fam Pract       Date:  1993-03       Impact factor: 2.267

2.  Randomised controlled trial of health promotion in general practice for patients at high cardiovascular risk.

Authors:  M E Cupples; A McKnight
Journal:  BMJ       Date:  1994-10-15

3.  Hepatitis B vaccination: the cost effectiveness of alternative strategies in England and Wales.

Authors:  P Mangtani; A J Hall; C E Normand
Journal:  J Epidemiol Community Health       Date:  1995-06       Impact factor: 3.710

4.  Strategies for reducing coronary risk factors in primary care: which is most cost effective?

Authors:  K Field; M Thorogood; C Silagy; C Normand; C O'Neill; J Muir
Journal:  BMJ       Date:  1995-04-29
  4 in total
  5 in total

Review 1.  The nurse as expert practitioner in global cardiovascular risk management.

Authors:  J Riley
Journal:  Heart       Date:  2003-05       Impact factor: 5.994

2.  Cost effectiveness of nurse led secondary prevention clinics for coronary heart disease in primary care: follow up of a randomised controlled trial.

Authors:  James P Raftery; Guiqing L Yao; Peter Murchie; Neil C Campbell; Lewis D Ritchie
Journal:  BMJ       Date:  2005-02-16

3.  Long-term cost effectiveness of cardiac secondary prevention in primary care in the Republic of Ireland and Northern Ireland.

Authors:  Paddy Gillespie; Edel Murphy; Susan M Smith; Margaret E Cupples; Molly Byrne; Andrew W Murphy
Journal:  Eur J Health Econ       Date:  2016-03-09

4.  Relative cost effectiveness of the SPHERE intervention in selected patient subgroups with existing coronary heart disease.

Authors:  Paddy Gillespie; Eamon O'Shea; Andrew W Murphy; Susan M Smith; Mary C Byrne; Molly Byrne; Margaret E Cupples
Journal:  Eur J Health Econ       Date:  2011-05-03

Review 5.  Economic evaluation of cholesterol-related interventions in general practice. An appraisal of the evidence.

Authors:  T van der Weijden; J A Knottnerus; A J Ament; H E Stoffers; R P Grol
Journal:  J Epidemiol Community Health       Date:  1998-09       Impact factor: 3.710

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.